Replies to post #408441 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

I hear this guy saying that the FDA "silver bullet" Amyloid plaque thesis is finally dead (note many recent FDA fails) and that CNS diseases (like AD) will use AVXL ("00 Buckshot-mixed loads).

"The changing therapeutic landscape" and "There are really interesting small molecules directed at disease modification"

[nidan7500]

kevindenver

2 comments stand out: "The changing therapeutic landscape" and "There are really interesting small molecules directed at disease modification" that could refer to the adding the small molecule blarcamesine to the changing "drug development pipeline".

CMON MAN ?? Are we supposed to infer a new AVXL specified path for CNS disease treatment is evolving along with the linked Bio-AI DNA thinking (So, we are each Bio-Micro unique and AVXL may hold micro key for tweaking/keeping balance in Micro-Bio cross functional integration) .

WHOA, no wonder Dr.M. is recruiting a new food tester from an undisclosed location.